An Unusual Tracheal Hemangioma Successfully Treated with Propranolol

Hugo Botto¹, Solís Marco^2, and Silvia Quadrelli²

¹Hospital de Pediatria Garrahan, Buenos Aires, Argentina

²Sanatorio Guemes, Buenos Aires, Argentina

Cite this paper

Hugo Botto, Solís Marco and Silvia Quadrelli. An Unusual Tracheal Hemangioma Successfully Treated with Propranolol. American Journal of Medical Case Reports. 2016; 4(7):242-244. doi: 10.12691/AJMCR-4-7-7

Abstract

A 2-month old, otherwise healthy infant male, presented with inspiratory stridor. A CT scan of the neck revealed an isolated decrease of the lumen in the middle third of the trachea. An MRI showed a markedly hyperintense lesion on T2-weighted images producing an obstruction of 80% of the airway lumen. A rigid bronchoscopy presented a submucosal port wine stain-like mass causing 90% obstruction of the airway at the level of the middle trachea and extending 1,5 cm down the airway. The patient was placed on oral propranolol at 2 mg/kg/day and showed a rapid response to the treatment, with regression of stridor and a significant reduction (less than 50%) of the mass in the images. A new bronchoscopy 3 months later revealed no airways obstruction.

Keywords

bening tumour, hemangioma, propranolol

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Holinger PH, BrownWT. Congenital webs, cysts, laryngoceles and other anomalies of the larynx. Ann Otol Rhinol Laryngol. 1967;76:744-752.
[2]	Cohen SR. Unusual lesion of the larynx, trachea and bronchial tree. Ann Otol Rhinol Laryngol. 1969;78:476-489.
[3]	Sharp HS. Hemangioma of the trachea in an infant, successful removal. J Laryngol Otol. 1949;63:413-414.
[4]	Denoyelle F, Leboulanger N, Enjolras O, et al. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol.2009; 73:1168-1172.
[5]	Orlow SJ, Isakoff MF, Blei F, Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a “beard” distribution. J Pediatr 1997;131:645-8
[6]	Saetti R, Silvestrini M, Cutrone C, Narne S. Arch Otolaryngol Head Neck Surg. 2008;134:848-851.
[7]	Leboulanger N, Fayoux P, Teissier N, et al. Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience. Int J Pediatr Otorhinolaryngol. 2010;74:1254-1257.
[8]	Badi AN, Kerschner JE, North PE, Drolet BA, Messner A, Perkins JA. Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study. Ann Otol Rhinol Laryngol. 1986 Jul-Aug;95(4 Pt 1):336-47.
[9]	Koplewitz BZ, Springer C, Slasky BS et al: CT of Hemangiomas of the Upper Airways in Children. Am J Roentgenol. 2005, 184:663-70.
[10]	Enguo Chen; Xianyan Yu; Ruifeng Zhang; Peipei Wang; Kejing Ying A large tracheal capillary hemangioma treated with interventional bronchoscopy hemangiomas treated interventional bronchoscopy large tracheal capillary hemangioma treated tracheal capillary hemangioma. 2011.
[11]	Bitar MA, Moukarbel RV, Zalzal GH. Management of congenital subglottic hemangioma: trends and success over the past 17 years. Otolaryngol Head Neck Surg. 2005;132:226-231.
[12]	Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358: 2649-2651.
[13]	Buckmiller L, Dyamenahalli U, Richter GT.Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope. 2009 Oct; 119(10):2051-4.
[14]	Vlastarakos PV, Papacharalampous GX, Chrysostomou M, Tavoulari EF, Delidis A, Protopapas D, et al. Propranolol is an effective treatment for airway haemangiomas: a critical analysis and meta-analysis of published interventional studies. Acta Otorhinolaryngol Ital. 2012 Aug;32(4):213-21.
[15]	Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013 Jan;131(1):128-40.
[16]	Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al.A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015 Feb 19;372(8):735-46.